Abstract:Conventional wisdom ascribes metabolic reprogramming in cancer to meeting increased demands for intermediates to support rapid proliferation. Prior models have proposed benefits toward cell survival, immortality, and stress resistance, although the recent discovery of oncometabolites has shifted attention to chromatin targets affecting gene expression. To explore further effects of cancer metabolism and epigenetic deregulation, DNA repair kinetics were examined in cells treated with metabolic intermediates, oncometabolites, and/or metabolic inhibitors by tracking resolution of double-strand breaks (DSB) in irradiated MCF7 breast cancer cells. Disrupting cancer metabolism revealed roles for both glycolysis and glutaminolysis in promoting DSB repair and preventing accelerated senescence after irradiation. Targeting pathways common to glycolysis and glutaminolysis uncovered opposing effects of the hexosamine biosynthetic pathway (HBP) and tricarboxylic acid (TCA) cycle. Treating cells with the HBP metabolite N-acetylglucosamine (GlcNAc) or augmenting protein O-GlcNAcylation with small molecules or RNAi targeting O-GlcNAcase each enhanced DSB repair, while targeting O-GlcNAc transferase reversed GlcNAc's effects. Opposing the HBP, TCA metabolites including α-ketoglutarate blocked DSB resolution. Strikingly, DNA repair could be restored by the oncometabolite 2-hydroxyglutarate (2-HG). Targeting downstream effectors of histone methylation and demethylation implicated the PRC1/2 polycomb complexes as the ultimate targets for metabolic regulation, reflecting known roles for Polycomb group proteins in nonhomologous end-joining DSB repair. Our findings that epigenetic effects of cancer metabolic reprogramming may promote DNA repair provide a molecular mechanism by which deregulation of metabolism may not only support cell growth but also maintain cell immortality, drive therapeutic resistance, and promote genomic instability. Implications: By defining a pathway from deregulated metabolism to enhanced DNA damage response in cancer, these data provide a rationale for targeting downstream epigenetic effects of metabolic reprogramming to block cancer cell immortality and overcome resistance to genotoxic stress. Mol Cancer Res; 14(2); 173–84. ©2015 AACR.

A Short Story with DNA Repair and Its Consequences on Cancer Therapy Resistance

Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.

The emerging relationship between metabolism and DNA repair

Cell Metabolism and DNA Repair Pathways: Implications for Cancer Therapy

Linking Cancer Metabolism to DNA Repair and Accelerated Senescence

DNA Damage, Repair, and Cancer Metabolism

Replication Fork Remodeling and Therapy Escape in DNA Damage Response-Deficient Cancers

Targeting DNA damage response pathways in cancer

Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies

DNA damage and metabolic mechanisms of cancer drug resistance

Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy

DNA Repair Pathways in Cancer Therapy and Resistance.

The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy

DNA Damage and Its Role in Cancer Therapeutics

Targeting DNA Repair Pathways: Mechanisms and Potential Applications in Cancer Therapy

The Importance of DNA Repair in Tumor Suppression

Nucleic Acid Sensing Pathways in DNA Repair Targeted Cancer Therapy

Recent advances in DNA damage repair mechanism

Strand-resolved mutagenicity of DNA damage and repair

Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair

Understanding the interplay between dNTP metabolism and genome stability in cancer